Versus GLP-1 agonists GLP-1 agonists like semaglutide and tirzepatide have become popular for metabolic optimization and weight loss
The complaint brought class action claims under both the federal TCPA and Floridas state-level equivalent, the FTSA
Only two peptides are currently approved for the treatment of tumors, mifamurtide for osteosarcoma and carfilzomib for multiple myeloma, and research into treatment strategies involving therapeutic peptides for more common tumors, such as lung cancer and gastric cancer, is still ongoing
Some individuals experience mild side effects such as nausea and GI symptoms, but these usually subside as your body adjusts
Evidence-based GHK-Cu protocol for hair loss: 1-2mg daily dosing, visible results in 12-16 weeks
Factors affecting speed include starting weight, diet quality, activity level, sleep, stress, and genetics